Novartis Offers High-Grade Debt to Fund $12 billion Avidity Deal
Novartis AG is seeking to raise debt to help fund its $12 billion acquisition of Avidity Biosciences Inc, adding to a flurry of M&A financing deals.
By Gerson Freitas Jr ยท Bloomberg Markets
Novartis AG is seeking to raise debt to help fund its $12 billion acquisition of Avidity Biosciences Inc, adding to a flurry of M&A financing deals.